SARomics Biostructures has opened a sales office in Cambridge, Massachusetts, in the U.S.
“We are excited about the move to this vibrant area and look forward to get the opportunity to work with world-class companies and their ground breaking projects,” says Björn Walse, CEO of SARomics Biostructures, whose headquarters is in the Medicon Valley region of southern Sweden.
The company is one of the leading structural biology providers in northern Europe and is known for its structure-based drug design skills and protein structure determination services. Recently the company has been focusing on structure determination of antibody – antigen complexes and is currently supporting clients in Asia, Europe and North America to pursue their therapeutic antibody development objectives.
SARomics utilizes the MAX IV Laboratory synchrotron in Lund for its research. In 2016 the next-generation MAX IV research facility will open as the most advanced synchrotron in the world. The company also has attracted significant funding for its internal research programs and is currently involved in three international research initiatives aiming at the discovery of leads for new medicines.
Source: SARomics Biostructures